综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Gilead Sciences unveils campaign to help women fight cancer

By Zhong Nan | chinadaily.com.cn | Updated: 2024-03-15 16:05
Share
Share - WeChat
The booth of Gilead Sciences at the fifth China International Import Expo in Shanghai on Nov 7, 2022. [Photo/VCG]

Gilead Sciences, a research-based biopharmaceutical company from California, launched a women's health advocacy campaign in China on Wednesday built around the idea of "taking back" the possibilities that cancer causes.

Themed "Cancer steals possibility. We're taking it back", the campaign, partnered with Marie Claire, a renowned women's lifestyle and fashion media, is a part of Gilead's global oncology franchise campaign. The project unites triple-negative breast cancer patients, authoritative medical experts and influential female representatives to share their personal experiences and stories of mutual support in the fight against cancer.

Breast cancer has become the leading type of cancer worldwide, with "triple-negative breast cancer" being a particularly difficult subtype to treat. This type of disease accounts for about between 10 to 15 percent of all breast cancers, according to information released by Atlanta-based American Cancer Society.

This form of breast cancer is highly aggressive and more likely to recur and spread than other types, posing a significant challenge for patient prognosis. The five-year survival rate for individuals with advanced metastatic triple-negative breast cancer is a mere 12.2 percent.

Jin Fangqian, vice-president of Gilead Sciences and the group's general manager for China, said as an innovation-driven company, Gilead is not only committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer, but also striving to remedy health inequities and break down barriers to care.

"By launching this campaign, we hope to further raise awareness of women's health in local society, enhance public understanding of breast cancer prevention and treatment, and help patients regain the possibilities in their lives," said Jin, adding the company will continue to invest in innovative research and development in the field of breast cancer and broader cancer types.

Gilead commenced its commercial operations in China in 2017, initially on virology focusing on HIV prevention and treatment, and viral hepatitis. By 2023, the company expanded into the oncology sector, introducing a new treatment option to China for patients with inoperable locally advanced or metastatic triple-negative breast cancer, offering innovative treatment option for those affected by this challenging condition.

In response to the Health China 2030 Initiative, the company has also collaborated with governments, associations, hospitals and research institutions to bring its innovative treatments to larger patient populations.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
西和县| 伊宁县| 江北区| 白银市| 道真| 葵青区| 郑州市| 昭通市| 延津县| 冀州市| 富顺县| 大理市| 寿阳县| 新野县| 曲水县| 三原县| 保德县| 涞水县| 五常市| 莱阳市| 六安市| 华安县| 高唐县| 隆化县| 九寨沟县| 武川县| 吴堡县| 淮滨县| 赤峰市| 光山县| 北安市| 巴东县| 忻州市| 遂川县| 永昌县| 合水县| 布尔津县| 福建省| 宁远县| 邓州市| 澄城县|